Harrison Global (BLMZ) builds ECRUX venture platform with Japan buy and Taiwan JV

Rhea-AI Filing Summary

Harrison Global Holdings Inc. is restructuring and expanding its venture investment business under a new global ECRUX platform. The board approved forming ECRUX Inc. in the United States and ECRUX Holdings Inc. in the Cayman Islands, each with authorized share capital of up to US$500,000, and an internal restructuring so Bloomz Limited becomes a subsidiary of ECRUX Holdings.

The company plans to acquire 100% of Japanese firm CSI Japan Co., Ltd. for about JPY 300,000, to be renamed ECRUX Venture Partners Japan Inc., and to complete this within 30 days. It also approved investing up to JPY 5,000,000 in RIKEN Taiwan Immune Regenerative Medicine Inc. for a 51% stake, to be renamed ECRUX Venture Partners Taiwan Inc., targeting completion within 60 days.

Insights

Cross-border M&A and strategy analyst

Harrison Global shifts into a structured Asia-focused venture platform under the ECRUX brand.

Harrison Global Holdings Inc. is formalizing its venture investment activities by creating a dedicated ECRUX platform with new U.S. and Cayman entities and moving Bloomz Limited under ECRUX Holdings. This centralizes control and branding around venture investments.

The company is adding on-the-ground capabilities in Japan and Taiwan. Bloomz Limited will buy 100% of CSI Japan Co., Ltd. for about JPY 300,000, while Korean subsidiary ECRUX Venture Partners, LLC will invest up to JPY 5,000,000 for a 51% stake in a Taiwan vehicle. Both targets will adopt ECRUX names, signaling an integrated regional network.

Execution depends on completing the new entities within 30–90 days and closing the Japan and Taiwan deals within 30–60 days, as indicated. Future disclosures in periodic reports may clarify financial contribution and performance of this ECRUX platform as it scales.

Key Figures

ECRUX Inc. authorized capital: US$500,000 ECRUX Holdings authorized capital: up to US$500,000 CSI Japan purchase consideration: JPY 300,000 +5 more

8 metrics

ECRUX Inc. authorized capital US$500,000 Authorized share capital for new U.S. subsidiary

ECRUX Holdings authorized capital up to US$500,000 Authorized share capital for new Cayman subsidiary

CSI Japan purchase consideration JPY 300,000 Consideration to acquire 100% of CSI Japan Co., Ltd.

Taiwan JV investment cap up to JPY 5,000,000 Maximum investment into RIKEN Taiwan Immune Regenerative Medicine Inc.

Taiwan JV ownership 51% Resulting stake in Taiwan company after investment

ECRUX Inc. timeline 30 days Expected completion of establishing ECRUX Inc.

ECRUX Holdings timeline 60 days Expected completion of establishing ECRUX Holdings Inc.

Internal restructuring timeline 90 days Expected completion of internal restructuring involving Bloomz Limited

Key Terms

wholly-owned subsidiary, authorized share capital, venture investment activities, forward-looking statements, +1 more

5 terms

wholly-owned subsidiary financial

"Formation of ECRUX Inc. in the United States as a wholly-owned subsidiary"

A wholly-owned subsidiary is a company whose entire ownership is held by another company, called the parent, so the parent controls all shares, board appointments and major decisions. For investors this matters because the subsidiary’s profits, losses, assets and liabilities are treated as part of the parent’s financial picture, affecting valuation and risk exposure — imagine a parent owning a single storefront outright and consolidating its receipts and bills into the parent’s books.

authorized share capital financial

"with authorized share capital of US$500,000"

The maximum number of shares a company is legally allowed to issue according to its governing documents. Think of it as the size of the blank checkbook a company keeps for selling ownership stakes: it sets an upper limit but does not mean all shares are in circulation. Investors care because a larger authorized amount makes it easier for the company to raise money or grant stock-based pay, which can dilute existing holdings and affect control and value per share.

venture investment activities financial

"designed to consolidate and expand the Company venture investment activities"

forward-looking statements regulatory

"This Report contains forward-looking statements within the meaning of applicable securities laws"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

joint venture financial

"The Board approved an investment in a Taiwan-based company to establish a regional investment platform"

A joint venture is when two or more companies team up to work on a specific project or business idea, sharing both the risks and the rewards. It’s like friends starting a lemonade stand together—each contributes resources and they split the profits, making it easier to succeed than going alone.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2026 Commission File Number: 001-42186 Harrison Global Holdings Inc. (f/k/a Bloomz Inc.) Cricket Square, Hutchins Drive, P.O. Box 2681 Grand Cayman, KY1-1111, Cayman Islands Adoption of Board Resolutions and Strategic Expansion Initiatives On March 17, 2026, the board of directors of Harrison Global Holdings Inc. (the Company) approved a series of unanimous written resolutions to implement a strategic restructuring and expansion of its global investment platform under the ECRUX brand. 1. Establishment of ECRUX Investment Platform The Board approved the establishment of a new global investment platform branded as ECRUX, designed to consolidate and expand the Company venture investment activities. Key actions include: Formation of ECRUX Inc. in the United States as a wholly-owned subsidiary, with authorized share capital of US$500,000. Formation of ECRUX Holdings Inc. in the Cayman Islands as a wholly-owned subsidiary, with authorized share capital of up to US$500,000. Implementation of an internal restructuring, pursuant to which Bloomz Limited will become a subsidiary of ECRUX Holdings Inc. Authorization for capital contributions and investments necessary to support the establishment and operations of these entities. Appointment of Ryoshin Nakade as the initial director of both entities. The Company expects to complete: Establishment of ECRUX Inc. within 30 days Establishment of ECRUX Holdings Inc. within 60 days Completion of internal restructuring within 90 days 2. Acquisition of Japanese Investment Company The Board approved the acquisition of CSI Japan Co., Ltd. by Bloomz Limited, a subsidiary of the Company, as part of its expansion into the Japanese market. Key terms include: Acquisition of 100% equity interest in CSI Japan Co., Ltd. Purchase consideration of approximately JPY 300,000 Post-acquisition corporate name change to: ECRUX Venture Partners Japan Inc. Expected completion within 30 days Following the acquisition, the proposed representatives of the entity will include: Kim Jung Ryoshin Nakade 3. Investment in Taiwan Joint Venture The Board approved an investment in a Taiwan-based company to establish a regional investment platform. Key elements include: Investment by ECRUX Venture Partners, LLC (a Korean subsidiary of the Company) into RIKEN Taiwan Immune Regenerative Medicine Inc. Total investment amount of up to JPY 5,000,000 Resulting ownership of 51% in the target company Post-investment name change to: ECRUX Venture Partners Taiwan Inc. Target completion within 60 days Proposed representatives include: Kim Jung Ryoshin Nakade 4. General Authorization The Board authorized any director or officer of the Company to execute all necessary documents and take all actions required to implement the above transactions and restructuring initiatives. Forward-Looking Statements This Report contains forward-looking statements within the meaning of applicable securities laws. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. The Company undertakes no obligation to update such statements except as required by law. Authorized SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Harrison Global Holdings Inc. By: /s/ Ryoshin Nakade Name: Ryoshin Nakade Title: Co-Chairman and Co-CEO Date: March 17, 2026

FAQ

What strategic changes is Harrison Global Holdings (BLMZ) making with the ECRUX platform?

Harrison Global Holdings is creating a dedicated ECRUX-branded global investment platform, adding new U.S. and Cayman subsidiaries and reorganizing Bloomz Limited under ECRUX Holdings. This structure is intended to consolidate and expand the company’s venture investment activities across multiple regions, including Japan and Taiwan.

What are the key details of Harrison Global’s acquisition of CSI Japan Co., Ltd.?

Bloomz Limited will acquire 100% of CSI Japan Co., Ltd. for approximately JPY 300,000. After closing, the company will be renamed ECRUX Venture Partners Japan Inc. The transaction is expected to be completed within 30 days, expanding Harrison Global’s presence in the Japanese investment market.

How is Harrison Global (BLMZ) expanding into Taiwan through the ECRUX platform?

Korean subsidiary ECRUX Venture Partners, LLC will invest up to JPY 5,000,000 into RIKEN Taiwan Immune Regenerative Medicine Inc. for a 51% ownership stake. After the investment, the entity will be renamed ECRUX Venture Partners Taiwan Inc., with target completion within 60 days, creating a regional investment hub.

What new entities is Harrison Global establishing for the ECRUX investment structure?

Harrison Global is forming ECRUX Inc. in the United States and ECRUX Holdings Inc. in the Cayman Islands as wholly-owned subsidiaries. Each will have authorized share capital of up to US$500,000, with Bloomz Limited becoming a subsidiary of ECRUX Holdings as part of an internal restructuring plan.

Who will lead the new ECRUX entities created by Harrison Global Holdings?

The board appointed Ryoshin Nakade as the initial director of both ECRUX Inc. in the United States and ECRUX Holdings Inc. in the Cayman Islands. Proposed representatives for the Japan and Taiwan ECRUX entities include Kim Jung and Ryoshin Nakade, aligning leadership across the regional investment platforms.

What are the expected timelines for Harrison Global’s restructuring and ECRUX expansion?

The company expects to establish ECRUX Inc. within 30 days and ECRUX Holdings Inc. within 60 days, with the internal restructuring completed within 90 days. The CSI Japan acquisition is targeted within 30 days, while the Taiwan joint venture investment aims to close within 60 days.